Skip to main content
. 2011 May 1;17(5):BR147–BR152. doi: 10.12659/MSM.881761

Table 4.

Percentage of false susceptibility to third- and fourth-generation cephalosporins in the groups of ESBL and AmpC producers when using the disk diffusion method.

Antibiotic False susceptibility (%)
CLSI criteria EUCAST criteria
Breakpoint (mm) ESBL strains (%) AmpC strains (%) Breakpoint (mm) ESBL strains (%) AmpC strains (%)
Cefoperazone ≥21 9 43 not stated
Cefotaxime ≥23 8 14 ≥21 11 29
Ceftazidime ≥18 45 14 ≥20 38 10
Cefepime ≥18 52 ≥24 19